Galderma Investigational Site (# 8515)

Nashville, Tennessee 37203

We've found

1 trials

at this facility

A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL)

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Nashville, TN

Use our guide to learn which trials are right for you!